JOHN MARAGANORE - 17 Jan 2022 Form 3 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Director
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Issuer symbol
KYMR
Transactions as of
17 Jan 2022
Transactions value $
$0
Form type
3
Filing time
19 Jan 2022, 16:30:18 UTC
Previous filing
23 Dec 2021
Next filing
19 Jan 2022

No securities are beneficially owned.